Wei Cui

Dr. Wei Cui


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
SXSiying Xiang
Siying Xiang
FLFufeng Liu
Fufeng Liu
JLJiajia Lin
Jiajia Lin
HCHuixin Chen
Huixin Chen
CHChunhui Huang
Chunhui Huang
JZJinrong Zhang
Jinrong Zhang

25 March 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JLJiajia Lin
Jiajia Lin
LHLing Huang
Ling Huang
JYJie Yu
Jie Yu
SXSiying Xiang
Siying Xiang
JWJialing Wang
Jialing Wang
QWQinwen Wang
Qinwen Wang
Fucoxanthin, a natural carotenoid abundant in edible brown seaweeds, has been shown to possess anti-cancer, anti-oxidant, anti-obesity and anti-diabetic effects. In this study, we report for the first time that fucoxanthin effectively protects against scopolamine-induced cognitive impairments in mice. In addition, fucoxanthin significantly reversed the scopolamine-induced increase of acetylcholinesterase (AChE) activity and decreased both choline acetyltransferase activity and brain-derived neurotrophic factor (BDNF) expression. Using an in vitro AChE activity assay, we discovered that fucoxanthin directly inhibits AChE with an IC50 value of 81.2 μM. Molecular docking analysis suggests that fucoxanthin likely interacts with the peripheral anionic site within AChE, which is in accordance with enzymatic activity results showing that fucoxanthin inhibits AChE in a non-competitive manner. Based on our current findings, we anticipate that fucoxanthin might exhibit great therapeutic efficacy for the treatment of Alzheimer’s disease by acting on multiple targets, including inhibiting AChE and increasing BDNF expression.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JLJiajia Lin
Jiajia Lin
JYJie Yu
Jie Yu
JZJiaying Zhao
Jiaying Zhao
KZKe Zhang
Ke Zhang
JZJiachen Zheng
Jiachen Zheng
SHShan He
Shan He
Alzheimer’s disease (AD), the most common neurodegenerative disorder, is characterized by neurofibrillary tangles, synaptic impairments, and loss of neurons. Oligomers of β‐amyloid (Aβ) are widely accepted as the main neurotoxins to induce oxidative stress and neuronal loss in AD. In this study, we discovered that fucoxanthin, a marine carotenoid with antioxidative stress properties, concentration dependently prevented Aβ oligomer‐induced increase of neuronal apoptosis and intracellular reactive oxygen species in SH‐SY5Y cells. Aβ oligomers inhibited the prosurvival phosphoinositide 3‐kinase (PI3K)/Akt cascade and activated the proapoptotic extracellular signal‐regulated kinase (ERK) pathway. Moreover, inhibitors of glycogen synthase kinase 3β (GSK3β) and mitogen‐activated protein kinase (MEK) synergistically prevented Aβ oligomer‐induced neuronal death, suggesting that the PI3K/Akt and ERK pathways might be involved in Aβ oligomer‐induced neurotoxicity. Pretreatment with fucoxanthin significantly prevented Aβ oligomer‐induced alteration of the PI3K/Akt and ERK pathways. Furthermore, LY294002 and wortmannin, two PI3K inhibitors, abolished the neuroprotective effects of fucoxanthin against Aβ oligomer‐induced neurotoxicity. These results suggested that fucoxanthin might prevent Aβ oligomer‐induced neuronal loss and oxidative stress via the activation of the PI3K/Akt cascade as well as inhibition of the ERK pathway, indicating that further studies of fucoxanthin and related compounds might lead to a useful treatment of AD.

18 August 2021 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
MYMengxiang Yang
Mengxiang Yang
LJLingli Jin
Lingli Jin
ZWZhuoying Wu
Zhuoying Wu
YXYanfei Xie
Yanfei Xie
PZPanpan Zhang
Panpan Zhang
Wei CuiWei Cui
Wei Cui

1 January 2017 in Food & Nutrition Research
Verified
Journal Article
Open access
PDF file
JYJie Yu
Jie Yu
JLJia-Jia Lin
Jia-Jia Lin
RYRui Yu
Rui Yu
SHShan He
Shan He
QWQin-Wen Wang
Qin-Wen Wang
JZJinrong Zhang
Jinrong Zhang
Background : As a natural carotenoid abundant in chloroplasts of edible brown algae, fucoxanthin possesses various health benefits, including anti-oxidative activity in particular. Objective : In the present study, we studied whether fucoxanthin protected against hydrogen peroxide (H 2 O 2 )-induced neuronal apoptosis. Design : The neuroprotective effects of fucoxanthin on H 2 O 2 -induced toxicity were studied in both SH-SY5Y cells and primary cerebellar granule neurons. Results : Fucoxanthin significantly protected against H 2 O 2 -induced neuronal apoptosis and intracellular reactive oxygen species. H 2 O 2 treatment led to the reduced activity of phosphoinositide 3-kinase (PI3-K)/Akt cascade and the increased activity of extracellular signal-regulated kinase (ERK) pathway in SH-SY5Y cells. Moreover, fucoxanthin significantly restored the altered activities of PI3-K/Akt and ERK pathways induced by H 2 O 2 . Both specific inhibitors of glycogen synthase kinase 3β (GSK3β) and mitogen-activated protein kinase kinase (MEK) significantly protected against H 2 O 2 -induced neuronal death. Furthermore, the neuroprotective effects of fucoxanthin against H 2 O 2 -induced neuronal death were abolished by specific PI3-K inhibitors. Conclusions : Our data strongly revealed that fucoxanthin protected against H 2 O 2 -induced neurotoxicity via concurrently activating the PI3-K/Akt cascade and inhibiting the ERK pathway, providing support for the use of fucoxanthin to treat neurodegenerative disorders induced by oxidative stress.

11 April 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CHChunhuu Huang
Chunhuu Huang
ZZZaijun Zhang
Zaijun Zhang
Wei CuiWei Cui
Wei Cui
Parkinson’s disease (PD) is a neurodegenerative disorder caused by the loss of dopaminergic neurons, leading to the motor dysfunctions of patients. Although the etiology of PD is still unclear, the death of dopaminergic neurons during PD progress was revealed to be associated with the abnormal aggregation of α-synuclein, the elevation of oxidative stress, the dysfunction of mitochondrial functions, and the increase of neuroinflammation. However, current anti-PD therapies could only produce symptom-relieving effects, because they could not provide neuroprotective effects, stop or delay the degeneration of dopaminergic neurons. Marine-derived natural compounds, with their novel chemical structures and unique biological activities, may provide anti-PD neuroprotective effects. In this study, we have summarized anti-PD marine-derived natural products which have shown pharmacological activities by acting on various PD targets, such as α-synuclein, monoamine oxidase B, and reactive oxygen species. Moreover, marine-derived natural compounds currently evaluated in the clinical trials for the treatment of PD are also discussed.